Cargando…
PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors
BACKGROUND: Counting mitoses is subjective and time-consuming. The adjunctive diagnostic utility of a recently reported mitotic marker, phosphohistone H3 (PHH3), was investigated in gastrointestinal stromal tumors (GISTs). METHODS: We reviewed 77 GISTs for several proliferative indices. These includ...
Autores principales: | Shin, Yooju, Hyeon, Jiyeon, Lee, Boram, Ha, Sang Yun, Hong, Min Eui, Do, In Gu, Kim, Kyoung-Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and The Korean Society for Cytopathology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357403/ https://www.ncbi.nlm.nih.gov/pubmed/25812654 http://dx.doi.org/10.4132/jptm.2014.10.08 |
Ejemplares similares
-
Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute
por: Shin, Yooju, et al.
Publicado: (2015) -
Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade
por: Mirzaiian, Elham, et al.
Publicado: (2020) -
Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
por: Ladstein, Rita G, et al.
Publicado: (2010) -
THU105 PHH Parameters Are New Minimal-Invasive Markers Of Glycemic Homeostasis Of Type 1 Diabetes
por: Harvengt, Antoine
Publicado: (2023) -
Pooling analysis on prognostic value of PHH3 expression in cancer patients
por: Hao, Qian, et al.
Publicado: (2018)